IRWD
HEALTHCAREIronwood Pharmaceuticals Inc - Class A
$4.83+0.16 (+3.43%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving IRWD Today?
No stock-specific AI insight has been generated for IRWD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.53$5.78
$4.83
Fundamentals
Market Cap$795M
P/E Ratio32.2
EPS$0.15
Dividend Yield—
Dividend / Share—
ROE-5.8%
Profit Margin0.1%
Debt / Equity—
Trading
Volume3.8M
Avg Volume (10D)—
Shares Outstanding164.6M
IRWD News
20 articles- Ironwood Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 7, 2026
- Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial GuidanceYahoo Finance·May 7, 2026
- Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)Yahoo Finance·May 4, 2026
- Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update CallYahoo Finance·Apr 30, 2026
- Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026Yahoo Finance·Apr 23, 2026
- Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?Yahoo Finance·Apr 21, 2026
- Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is WhyYahoo Finance·Mar 31, 2026
- IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?Yahoo Finance·Mar 30, 2026
- Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?Yahoo Finance·Mar 27, 2026
- Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround PotentialMotley Fool·Mar 23, 2026
- IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?Yahoo Finance·Mar 12, 2026
- Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4?Yahoo Finance·Mar 6, 2026
- Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences ConferenceYahoo Finance·Mar 4, 2026
- A Look At Ironwood Pharmaceuticals (IRWD) Valuation After Q4 2025 Results And 2026 Revenue GuidanceYahoo Finance·Feb 27, 2026
- Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ...Yahoo Finance·Feb 25, 2026
- Ironwood Pharmaceuticals Q4 Earnings Call HighlightsMarketbeat·Feb 25, 2026
- Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 25, 2026
- Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Feb 25, 2026
- Ironwood: Q4 Earnings SnapshotYahoo Finance·Feb 25, 2026
All 20 articles loaded
Price Data
Open$4.14
Previous Close$4.67
Day High$4.48
Day Low$4.08
52 Week High$5.78
52 Week Low$0.53
52-Week Range
$0.53$5.78
$4.83
Fundamentals
Market Cap$795M
P/E Ratio32.2
EPS$0.15
Dividend Yield—
Dividend / Share—
ROE-5.8%
Profit Margin0.1%
Debt / Equity—
Trading
Volume3.8M
Avg Volume (10D)—
Shares Outstanding164.6M
About Ironwood Pharmaceuticals Inc - Class A
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—